Logo image of DAVE

DAVE INC (DAVE) Stock Fundamental Analysis

USA - NASDAQ:DAVE - US23834J2015 - Common Stock

229.42 USD
+4.55 (+2.02%)
Last: 9/12/2025, 8:00:01 PM
229 USD
-0.42 (-0.18%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DAVE. DAVE was compared to 54 industry peers in the Consumer Finance industry. DAVE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DAVE is valued quite expensively, but it does show have an excellent growth rating. This makes DAVE very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

DAVE had positive earnings in the past year.
DAVE had a positive operating cash flow in the past year.
DAVE had negative earnings in 4 of the past 5 years.
In multiple years DAVE reported negative operating cash flow during the last 5 years.
DAVE Yearly Net Income VS EBIT VS OCF VS FCFDAVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 15.16%, DAVE belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
DAVE's Return On Equity of 25.39% is amongst the best of the industry. DAVE outperforms 87.04% of its industry peers.
The Return On Invested Capital of DAVE (24.09%) is better than 90.74% of its industry peers.
Industry RankSector Rank
ROA 15.16%
ROE 25.39%
ROIC 24.09%
ROA(3y)-12.42%
ROA(5y)-12%
ROE(3y)-48.35%
ROE(5y)-42.15%
ROIC(3y)N/A
ROIC(5y)N/A
DAVE Yearly ROA, ROE, ROICDAVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

DAVE has a Profit Margin (12.73%) which is in line with its industry peers.
In the last couple of years the Profit Margin of DAVE has grown nicely.
DAVE has a Operating Margin of 23.04%. This is in the better half of the industry: DAVE outperforms 70.37% of its industry peers.
In the last couple of years the Operating Margin of DAVE has grown nicely.
Industry RankSector Rank
OM 23.04%
PM (TTM) 12.73%
GM N/A
OM growth 3YN/A
OM growth 5Y33.38%
PM growth 3YN/A
PM growth 5Y73.85%
GM growth 3YN/A
GM growth 5YN/A
DAVE Yearly Profit, Operating, Gross MarginsDAVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DAVE is creating value.
The number of shares outstanding for DAVE has been increased compared to 1 year ago.
DAVE has less shares outstanding than it did 5 years ago.
DAVE has a better debt/assets ratio than last year.
DAVE Yearly Shares OutstandingDAVE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DAVE Yearly Total Debt VS Total AssetsDAVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

DAVE has an Altman-Z score of 15.36. This indicates that DAVE is financially healthy and has little risk of bankruptcy at the moment.
DAVE has a Altman-Z score of 15.36. This is amongst the best in the industry. DAVE outperforms 100.00% of its industry peers.
DAVE has a debt to FCF ratio of 0.40. This is a very positive value and a sign of high solvency as it would only need 0.40 years to pay back of all of its debts.
DAVE's Debt to FCF ratio of 0.40 is amongst the best of the industry. DAVE outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that DAVE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.35, DAVE is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 0.4
Altman-Z 15.36
ROIC/WACC2.25
WACC10.69%
DAVE Yearly LT Debt VS Equity VS FCFDAVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 9.51 indicates that DAVE has no problem at all paying its short term obligations.
DAVE has a Current ratio of 9.51. This is amongst the best in the industry. DAVE outperforms 94.44% of its industry peers.
DAVE has a Quick Ratio of 9.51. This indicates that DAVE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of DAVE (9.51) is better than 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 9.51
Quick Ratio 9.51
DAVE Yearly Current Assets VS Current LiabilitesDAVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

DAVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1069.23%, which is quite impressive.
Measured over the past years, DAVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 126.65% on average per year.
DAVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.97%.
DAVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.42% yearly.
EPS 1Y (TTM)1069.23%
EPS 3YN/A
EPS 5Y126.65%
EPS Q2Q%31.91%
Revenue 1Y (TTM)47.97%
Revenue growth 3Y31.39%
Revenue growth 5Y35.42%
Sales Q2Q%64.42%

3.2 Future

Based on estimates for the next years, DAVE will show a very strong growth in Earnings Per Share. The EPS will grow by 56.73% on average per year.
The Revenue is expected to grow by 17.51% on average over the next years. This is quite good.
EPS Next Y269.76%
EPS Next 2Y133.85%
EPS Next 3Y81.71%
EPS Next 5Y56.73%
Revenue Next Year47.23%
Revenue Next 2Y30.28%
Revenue Next 3Y22.64%
Revenue Next 5Y17.51%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DAVE Yearly Revenue VS EstimatesDAVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
DAVE Yearly EPS VS EstimatesDAVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 5 -5 10 -10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 60.69, the valuation of DAVE can be described as expensive.
Based on the Price/Earnings ratio, DAVE is valued more expensive than 81.48% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. DAVE is valued rather expensively when compared to this.
DAVE is valuated rather expensively with a Price/Forward Earnings ratio of 23.57.
72.22% of the companies in the same industry are cheaper than DAVE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. DAVE is around the same levels.
Industry RankSector Rank
PE 60.69
Fwd PE 23.57
DAVE Price Earnings VS Forward Price EarningsDAVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DAVE is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAVE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.71
EV/EBITDA 28.27
DAVE Per share dataDAVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DAVE's earnings are expected to grow with 81.71% in the coming years.
PEG (NY)0.22
PEG (5Y)0.48
EPS Next 2Y133.85%
EPS Next 3Y81.71%

0

5. Dividend

5.1 Amount

No dividends for DAVE!.
Industry RankSector Rank
Dividend Yield N/A

DAVE INC

NASDAQ:DAVE (9/12/2025, 8:00:01 PM)

After market: 229 -0.42 (-0.18%)

229.42

+4.55 (+2.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners74.64%
Inst Owner Change11.13%
Ins Owners13.68%
Ins Owner Change-1.12%
Market Cap3.10B
Analysts82.86
Price Target268.13 (16.87%)
Short Float %11%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.03%
Min EPS beat(2)-59.65%
Max EPS beat(2)133.71%
EPS beat(4)3
Avg EPS beat(4)92.77%
Min EPS beat(4)-59.65%
Max EPS beat(4)170.78%
EPS beat(8)7
Avg EPS beat(8)127.84%
EPS beat(12)10
Avg EPS beat(12)91.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.12%
Min Revenue beat(2)12.48%
Max Revenue beat(2)13.76%
Revenue beat(4)4
Avg Revenue beat(4)10.56%
Min Revenue beat(4)3.64%
Max Revenue beat(4)13.76%
Revenue beat(8)8
Avg Revenue beat(8)8.06%
Revenue beat(12)9
Avg Revenue beat(12)5.17%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.17%
PT rev (3m)36.38%
EPS NQ rev (1m)14%
EPS NQ rev (3m)36.99%
EPS NY rev (1m)-7.02%
EPS NY rev (3m)28.54%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)8.3%
Revenue NY rev (1m)7.48%
Revenue NY rev (3m)7.48%
Valuation
Industry RankSector Rank
PE 60.69
Fwd PE 23.57
P/S 7.15
P/FCF 16.71
P/OCF 16.11
P/B 14.27
P/tB 15.25
EV/EBITDA 28.27
EPS(TTM)3.78
EY1.65%
EPS(NY)9.73
Fwd EY4.24%
FCF(TTM)13.73
FCFY5.98%
OCF(TTM)14.24
OCFY6.21%
SpS32.08
BVpS16.08
TBVpS15.05
PEG (NY)0.22
PEG (5Y)0.48
Profitability
Industry RankSector Rank
ROA 15.16%
ROE 25.39%
ROCE 30.5%
ROIC 24.09%
ROICexc 35.14%
ROICexgc 37.47%
OM 23.04%
PM (TTM) 12.73%
GM N/A
FCFM 42.79%
ROA(3y)-12.42%
ROA(5y)-12%
ROE(3y)-48.35%
ROE(5y)-42.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y23.23%
ROICexc growth 3YN/A
ROICexc growth 5Y23.31%
OM growth 3YN/A
OM growth 5Y33.38%
PM growth 3YN/A
PM growth 5Y73.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 0.4
Debt/EBITDA 0.7
Cap/Depr 94.21%
Cap/Sales 1.6%
Interest Coverage 13.75
Cash Conversion 179.47%
Profit Quality 336.18%
Current Ratio 9.51
Quick Ratio 9.51
Altman-Z 15.36
F-Score9
WACC10.69%
ROIC/WACC2.25
Cap/Depr(3y)127.95%
Cap/Depr(5y)168.19%
Cap/Sales(3y)3.35%
Cap/Sales(5y)3.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1069.23%
EPS 3YN/A
EPS 5Y126.65%
EPS Q2Q%31.91%
EPS Next Y269.76%
EPS Next 2Y133.85%
EPS Next 3Y81.71%
EPS Next 5Y56.73%
Revenue 1Y (TTM)47.97%
Revenue growth 3Y31.39%
Revenue growth 5Y35.42%
Sales Q2Q%64.42%
Revenue Next Year47.23%
Revenue Next 2Y30.28%
Revenue Next 3Y22.64%
Revenue Next 5Y17.51%
EBIT growth 1Y4293.4%
EBIT growth 3YN/A
EBIT growth 5Y80.63%
EBIT Next Year527.05%
EBIT Next 3Y66.1%
EBIT Next 5Y68.22%
FCF growth 1Y849.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1340.19%
OCF growth 3YN/A
OCF growth 5YN/A